Alterations in cultured myocardial fibroblast function following the development of left ventricular failure

被引:39
作者
Flack, EC [1 ]
Lindsey, ML [1 ]
Squires, CE [1 ]
Kaplan, BS [1 ]
Stroud, RE [1 ]
Clark, LL [1 ]
Escobar, PG [1 ]
Yarbrough, WN [1 ]
Spinale, FG [1 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29403 USA
关键词
myocardial matrix; fibroblast migration; heart failure; matrix metalloproteinases; integrins;
D O I
10.1016/j.yjmcc.2006.01.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A structural event in the progression of left ventricular (LV) failure is myocardial extracellular matrix (ECM) remodeling. The myocardial fibroblast is a major cell type influencing the ECM, but whether and to what degree specific phenotypic differences in myocardial fibroblasts can be demonstrated to occur in culture with the development of LV failure remains unclear. Adult pigs (25 kg) were used for control myocardial fibroblast preparations (N=5) or following pacing-induced LV failure (N=5; 240 bpm, 3 weeks). LV remodeling occurred with pacing as evidenced by increased LV end diastolic volume (132 +/- 11 vs. 60 +/- 4 mL for control; P < 0.05). Functional parameters including migration, adhesion, collagen and matrix metalloproteinase release were assessed in fibroblast cultures from passages 1-4. The following findings were consistent with each passage and the results were analyzed with control values set to 100%. Migration of LV failure fibroblasts increased by over 170% (P < 0.05). Adhesion to collagen 1, laminin and fibronectin was increased by over 160% in LV failure fibroblasts (P < 0.05). beta(1) integrin density decreased by 50% in LV failure fibroblasts (P < 0.05). Fibrillar collagen release increased by over 130% and matrix metalloproteinase-2 increased by 140% in LV failure fibroblasts (P < 0.05). The unique findings of this study are two-fold. First, after a pathological stimulus in-vivo, adult myocardial fibroblasts maintain a consistent phenotype through early passages in-vivo. Second, a differential release of, and response to ECM components occurred in LV failure fibroblasts. Thus, a phenotypic transformation of the myocardial fibroblast occurs with the development of LV failure, which in turn may contribute to matrix remodeling and presents as a potential cellular therapeutic target. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:474 / 483
页数:10
相关论文
共 46 条
[1]   Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E [J].
Asbun, J ;
Manso, AM ;
Villarreal, FJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (01) :H227-H234
[2]   A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers [J].
Bergman, MR ;
Cheng, S ;
Honbo, N ;
Piacentini, L ;
Karliner, JS ;
Lovett, DH .
BIOCHEMICAL JOURNAL, 2003, 369 (03) :485-496
[3]   Myocardial fibrosis in chronic aortic regurgitation - Molecular and cellular responses to volume overload [J].
Borer, JS ;
Truter, S ;
Herrold, EM ;
Falcone, DJ ;
Pena, M ;
Carter, JN ;
Dumlao, TF ;
Lee, JA ;
Supino, PG .
CIRCULATION, 2002, 105 (15) :1837-1842
[4]   Differential integrin expression by cardiac fibroblasts from hypertensive and exercise-trained rat hearts [J].
Burgess, ML ;
Terracio, L ;
Hirozane, T ;
Borg, TK .
CARDIOVASCULAR PATHOLOGY, 2002, 11 (02) :78-87
[5]   INTEGRIN-MEDIATED COLLAGEN GEL CONTRACTION BY CARDIAC FIBROBLASTS - EFFECTS OF ANGIOTENSIN-II [J].
BURGESS, ML ;
CARVER, WE ;
TERRACIO, L ;
WILSON, SP ;
WILSON, MA ;
BORG, TK .
CIRCULATION RESEARCH, 1994, 74 (02) :291-298
[6]   Structural and functional characterisation of cardiac fibroblasts [J].
Camelliti, P ;
Borg, TK ;
Kohl, P .
CARDIOVASCULAR RESEARCH, 2005, 65 (01) :40-51
[7]   COLLAGEN EXPRESSION IN MECHANICALLY STIMULATED CARDIAC FIBROBLASTS [J].
CARVER, W ;
NAGPAL, ML ;
NACHTIGAL, M ;
BORG, TK ;
TERRACIO, L .
CIRCULATION RESEARCH, 1991, 69 (01) :116-122
[8]   Matrix metalloproteinase abundance in human myocardial fibroblasts: effects of sustained pharmacologic matrix metalloproteinase inhibition [J].
Chapman, RE ;
Scott, AA ;
Deschamps, AM ;
Lowry, AS ;
Stroud, RE ;
Ikonomidis, JS ;
Spinale, FG .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (05) :539-548
[9]   Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure? [J].
Creemers, EEJM ;
Cleutjens, JPM ;
Smits, JFM ;
Daemen, MJAP .
CIRCULATION RESEARCH, 2001, 89 (03) :201-210